Highlights
A collection of news and information related to Oncolytics Biotech Incorporated published by this site and its partners.
Displaying items 1-2 of 2
» View wsbt.com items only
-
BRIEF-Oncolytics Biotech U.S.-listed shares jump 10.3 percent premarket
ReutersNEW YORK, May 22 (Reuters) - Oncolytics Biotech Inc : * Oncolytics Biotech U.S.-listed shares jump 10.3 percent to $3 in premarket after phase 2 metastatic melanoma trial resultsTags: Skin Cancer
-
Oncolytics cancer drug meets mid-stage trial goal, shares rise
ReutersMay 22 (Reuters) - Oncolytics Biotech Inc said preliminary data from a mid-stage trial showed that its cancer drug, Reolysin, met the main goal of reducing the size of tumors in patients with metastatic melanoma, a type of skin cancer. Shares of the...Tags: Stock Market, Skin Cancer, Science and Technology, Toronto Stock Exchange, Chemotherapy
May 22, 2013
|Story| Reuters
May 22, 2013
|Story| Reuters
Original site for Oncolytics Biotech Incorporated topic gallery.